metastatic lung cancer
Showing 1 - 25 of >10,000
Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)
Not yet recruiting
- Elderly Patients
- Metastatic Lung Cancer
- Single drug chemotherapy plus immunotherapy
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 15, 2023
NSCLC Trial (SABR, SoC systemic therapy)
Recruiting
- NSCLC
- SABR
- SoC systemic therapy
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Nov 7, 2022
Resistance-associated Mutations in Metastatic Lung Cancer
Recruiting
- Lung Cancer
- Liquid biopsy
-
Monza, MB, ItalyFondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023
Lung Cancer Metastatic Trial in Durham (Dialectical Behavioral Therapy Skills Training)
Recruiting
- Lung Cancer Metastatic
- Dialectical Behavioral Therapy Skills Training
-
Durham, North CarolinaDuke Cancer Institute
Jun 14, 2022
Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples
Recruiting
- Non-squamous Lung Cancer
- Metastatic Lung Cancer
- Blood
- +3 more
-
Tours, FranceUniversity hospital
Nov 7, 2022
Metastatic Lung Cancer Trial in Beer sheva, Petah Tikva (Antibiotics, FMT (Fecal Microbiota Transplantation), Placebo
Not yet recruiting
- Metastatic Lung Cancer
- Antibiotics
- +3 more
-
Beer sheva, Israel
- +1 more
Aug 14, 2022
Lung Cancer Trial in Angers, St Herblain (Metastasis biopsy)
Not yet recruiting
- Lung Cancer
- Metastasis biopsy
-
Angers, France
- +1 more
Jul 26, 2022
Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)
Completed
- Lung Cancer
- Metastatic Cancer
- Cryotherapy (PTC)
- Prednisone
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 29, 2022
Emulation of KEYNOTE-189 Trial Using Electronic Health Records
Active, not recruiting
- Non-small Cell Lung Cancer
- Metastatic Lung Cancer
- Pembrolizumab + Pemetrexed-Platinum
- Pemetrexed-Platinum
-
Boston, MassachusettsAetion
Jun 14, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer Trial (FoundationOne® Liquid CDx Assay, Standard of Care Diagnostic
Not yet recruiting
- Metastatic Lung Cancer
- Metastatic Gastrointestinal Cancer
- FoundationOne® Liquid CDx Assay
- Standard of Care Diagnostic Pathway
- (no location specified)
May 11, 2023
Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer Trial in New Taipei City, Taipei
Completed
- Metastatic Gastric Cancer
- +3 more
-
New Taipei City, Taiwan
- +3 more
Sep 21, 2022
Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)
Not yet recruiting
- Metastatic Lung Cancer
- +2 more
- Tusamitamab ravtansine
-
Rotterdam, NetherlandsErasmus MC
Jan 26, 2023
Metastatic Lung Cancer Trial in Lexington (Pathways)
Recruiting
- Metastatic Lung Cancer
- Pathways
-
Lexington, KentuckyUniversity of Kentucky
Jan 13, 2022
Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)
Active, not recruiting
- Metastatic Lung Cancer
- InvisionFirst® molecular panel
-
Bayeux, France
- +15 more
Aug 22, 2022
Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Port Saint Lucie, Florida
- +1 more
Aug 11, 2023
Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)
Recruiting
- Cancer
- +11 more
-
San Antonio, TexasSouth Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023
NSCLC Trial in Guangzhou (BL-M07D1)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 1, 2023
Cancer Medicines in Metastatic Non-small Cell Lung Cancer in
Not yet recruiting
- Non-Small Cell Lung Cancer
- lorlatinib
- +17 more
-
Oslo, NorwayPfizer Norway
Apr 17, 2023
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022
Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- +7 more
- WM-A1-3389
- Pembrolizumab
-
Seoul, Seocho-gu, Korea, Republic of
- +1 more
May 14, 2023
Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)
Recruiting
- Non-Small-Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 25, 2023
NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tislelizumab IV
- +2 more
- (no location specified)
Oct 25, 2023